Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis

HSP90 and the chaperoning of cancer

Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502 · see citing works

Addiction to Oncogenes--the Achilles Heal of Cancer

Weinstein, I. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,753 · see citing works

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,380 · see citing works

The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions

Daugaard, M., Rohde, M., & Jäättelä, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.039 · Cited by 1,161 · see citing works

Pathways of chaperone-mediated protein folding in the cytosol

Young, J. C., Agashe, V. R., Siegers, K., & Hartl, F. U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1492 · Cited by 1,101 · see citing works

Strategies for silencing human disease using RNA interference

Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078 · see citing works

Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties

Garrido, C., Brunet, M., Mirjolet, C., Zermati, Y., Schmitt, E., & Kroemer, G. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3448 · Cited by 676 · see citing works

Drugging the Cancer Chaperone HSP90

Workman, P., Burrows, F. J., Neckers, L., & Rosen, N. X. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.012 · Cited by 525 · see citing works

Molecular chaperones and the stress of oncogenesis

Mosser, D. D., & Morimoto, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207529 · Cited by 500 · see citing works

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies

Banerji, U., O’Donnell, A. E., Scurr, M. R., Pacey, S., Stapleton, S., Asad, Y. J., Simmons, L., Maloney, A., Raynaud, F. I., Campbell, M. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.612 · Cited by 490 · see citing works

Polyubiquitination and Proteasomal Degradation of the p185c-B-2 Receptor Protein-tyrosine Kinase Induced by Geldanamycin

Mimnaugh, E. G., Chavany, C., & Neckers, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22796 · Cited by 466 · see citing works

Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases

Raynaud, F. I., Eccles, S. A., Clarke, P. A., Hayes, A., Nutley, B. P., Alix, S., Henley, A. T., Di-Stefano, F., Ahmad, Z., Guillard, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4615 · Cited by 350 · see citing works

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Advanced Cancer

Goetz, M. P., Toft, D. O., Reid, J. M., Ames, M. M., Stensgard, B. A., Safgren, S. L., Adjei, A. A., Sloan, J. A., Atherton, P. J., Vasile, V. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.119 · Cited by 334 · see citing works

Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.

Hostein, I., Robertson, D. M., Di-Stefano, F., Workman, P., & Clarke, P. A. (2001) · PubMed · Cited by 284 · see citing works

Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone

Workman, P. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.032 · Cited by 245 · see citing works

Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells.

Yokota, S., Kitahara, M., & Nagata, K. (2000) · PubMed · Cited by 228 · see citing works

Triptolide, an Inhibitor of the Human Heat Shock Response That Enhances Stress-induced Cell Death

Westerheide, S. D., Kawahara, T. L. A., Orton, K., & Morimoto, R. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512044200 · Cited by 226 · see citing works

Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin

Guo, F., Rocha, K., Bali, P., Pranpat, M., Fiskus, W. C., Boyapalle, S., Kumaraswamy, S., Balasis, M. E., Greedy, B. M., Armitage, E. S. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1799 · Cited by 212 · see citing works

Heat Shock Protein 70 Is Required for the Survival of Cancer Cells

Nylandsted, J., Brand, K., & Jäättelä, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05605.x · Cited by 200 · see citing works

Folding of the Glucocorticoid Receptor by the Reconstituted hsp90-based Chaperone Machinery

Dittmar, K. D., & Pratt, W. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13047 · Cited by 183 · see citing works

Stepwise Assembly of a Glucocorticoid Receptor·hsp90 Heterocomplex Resolves Two Sequential ATP-dependent Events Involving First hsp70 and Then hsp90 in Opening of the Steroid Binding Pocket

Morishima, Y., Murphy, P. J. M., Li, D.-P., Sanchez, E. R., & Pratt, W. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000434200 · Cited by 166 · see citing works

Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft Models

Banerji, U., Walton, M. I., Raynaud, F. I., Grimshaw, R., Kèlland, L. R., Valenti, M., Judson, I. R., & Workman, P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0518 · Cited by 164 · see citing works

Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion.

Nylandsted, J., Wick, W., Hirt, U. A., Brand, K., Rohde, M., Leist, M., Weller, M., & Jäättelä, M. (2002) · PubMed · Cited by 141 · see citing works

Gene and Protein Expression Profiling of Human Ovarian Cancer Cells Treated with the Heat Shock Protein 90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin

Maloney, A., Clarke, P. A., Naaby‐Hansen, S., Stein, R. C., Koopman, J.-O., Akpan, A., Yang, A., Zvelebil, M., Cramer, R., Stimson, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2968 · Cited by 138 · see citing works

Increased expression of the major heat shock protein Hsp72 in human prostate carcinoma cells is dispensable for their viability but confers resistance to a variety of anticancer agents

Gabai, V. L., Budagova, K. R., & Sherman, M. Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208495 · Cited by 127 · see citing works

In vitro Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors

Sharp, S. Y., Boxall, K. J., Rowlands, M., Prodromou, C., Roe, S. M., Maloney, A., Powers, M. V., Clarke, P. A., Box, G., Sanderson, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3473 · Cited by 112 · see citing works

Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy

Sliutz, G., Karlseder, J., Tempfer, C. M., Orel, L., Holzer, G., & Simon, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.334 · Cited by 98 · see citing works

Identification of an Inhibitor of hsc70-mediated Protein Translocation and ATP Hydrolysis

Fewell, S. W., Day, B. W., & Brodsky, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008535200 · Cited by 66 · see citing works

Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis

Ronen, S. M., Di-Stefano, F., McCoy, C. L., Robertson, D. M., Smith, T., Al-Saffar, N. M. S., Titley, J. C., Cunningham, D., Griffiths, J. R., Leach, M. O., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690459 · Cited by 52 · see citing works

Selectivity of the molecular chaperone-specific immunosuppressive agent 15-deoxyspergualin

Brodsky, J. L. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00376-1 · Cited by 46 · see citing works

Measuring Ubiquitin Conjugation in Cells

Mimnaugh, E. G., & Neckers, L. Μ. (2005) · Humana Press eBooks · doi:10.1385/1-59259-895-1:223 · Cited by 15 · see citing works

Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines

Håvik, B., & Bramham, C. R. (2007) · Oncology Reports · doi:10.3892/or.17.6.1501 · Cited by 15 · see citing works

Targeting the dynamic HSP90 complex in cancer

Trepel, J. B., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2887 · Cited by 1,523 · see citing works

Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?

Neckers, L., & Workman, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1000 · Cited by 960 · see citing works

The HSP70 family and cancer

Murphy, M. E. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt111 · Cited by 505 · see citing works

Endoplasmic reticulum stress in malignancy.

Clarke, H. J., Chambers, J. E., Liniker, E., & Marciniak, S. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.015 · Cited by 454 · see citing works

Targeting heat shock proteins in cancer

Jégo, G., Hazoumé, A., Seigneuric, R., & Garrido, C. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.014 · Cited by 453 · see citing works

A Small Molecule Inhibitor of Inducible Heat Shock Protein 70

Leu, J. I.-J., Pimkina, J. S., Frank, A. K., Murphy, M. E., & George, D. L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.023 · Cited by 442 · see citing works

Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target

Evans, C. G., Chang, L., & Gestwicki, J. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100054f · Cited by 438 · see citing works

HSPA8/HSC70 chaperone protein

Stricher, F., Macri, C., Ruff, M., & Muller, S. (2013) · Autophagy · doi:10.4161/auto.26448 · Cited by 420 · see citing works

Inhibition of HSP90 molecular chaperones: moving into the clinic

García‐Carbonero, R., Carnero, A., & Paz-Ares, L. G. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70169-4 · Cited by 351 · see citing works

Targeting HSP90 for cancer therapy

Mahalingam, D., Swords, R. T., Carew, J. S., Nawrocki, S. T., Bhalla, K. N., & Giles, F. J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605066 · Cited by 323 · see citing works

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

Massey, A. J., Williamson, D. S., Browne, H. L., Murray, J. B., Dokurno, P., Shaw, T., Macias, A. T., Daniels, Z., Geoffroy, S., Dopson, M., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1194-3 · Cited by 314 · see citing works

Aneuploidy causes proteotoxic stress in yeastPreprint

Oromendia, A. B., Dodgson, S. E., & Amon, A. (2012) · Genes & Development · doi:10.1101/gad.207407.112 · Cited by 307 · see citing works

Probing the Probes: Fitness Factors For Small Molecule Tools

Workman, P., & Collins, I. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.013 · Cited by 300 · see citing works

Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update

Ciocca, D. R., Arrigo, A. P., & Calderwood, S. K. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0918-z · Cited by 264 · see citing works

Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions

Hong, D. S., Banerji, U., Tavana, B., George, G. C., Aaron, J., & Kurzrock, R. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.10.001 · Cited by 259 · see citing works

Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?

Attard, G., Cooper, C. S., & de Bono, J. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.11.006 · Cited by 242 · see citing works

Inhibition of HSP70: A challenging anti-cancer strategy

Goloudina, A. R., Demidov, O. N., & Garrido, C. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.003 · Cited by 232 · see citing works

Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design

Williamson, D. S., Borgognoni, J., Clay, A., Daniels, Z., Dokurno, P., Drysdale, M. J., Foloppe, N., Francis, G. L., Graham, C. J., Howes, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801627a · Cited by 228 · see citing works

Targeting Hsp70: A possible therapy for cancer

Kumar, S., Stokes, J. A., III, Singh, U. P., Gunn, K. S., Acharya, A., Manne, U., & Mishra, M. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.056 · Cited by 225 · see citing works

Firefly luciferase mutants as sensors of proteome stress

Gupta, R., Kasturi, P., Bracher, A., Loew, C., Zheng, M., Villella, A., Garza, D., Hartl, F. U., & Raychaudhuri, S. (2011) · Nature Methods · doi:10.1038/nmeth.1697 · Cited by 219 · see citing works

Hsp70 in cancer: back to the future

Sherman, M. Y., & Gabai, V. L. (2014) · Oncogene · doi:10.1038/onc.2014.349 · Cited by 213 · see citing works

Maximizing the Therapeutic Potential of HSP90 Inhibitors

Butler, L. M., Ferraldeschi, R., Armstrong, H., Centenera, M. M., & Workman, P. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0234 · Cited by 208 · see citing works

Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction*

Zhang, T., Li, Y.-Y., Yu, Y.-K., Zou, P., Jiang, Y.-Q., & Sun, D.-X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051532 · Cited by 189 · see citing works

Functional Analysis of Hsp70 Inhibitors

Schlecht, R., Scholz, S., Dahmen, H., Wegener, A., Sirrenberg, C., Musil, D., Bomke, J., Eggenweiler, H., Mayer, M. P., & Bukau, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078443 · Cited by 191 · see citing works

Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry

Isabelle, M., Moreel, X., Gagné, J., Rouleau, M., Ethier, C., Gagné, P., Hendzel, M. J., & Poirier, G. G. (2010) · Proteome Science · doi:10.1186/1477-5956-8-22 · Cited by 164 · see citing works

The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma

Chatterjee, M., Andrulis, M., Stühmer, T., Muller, E., Hofmann, C., Steinbrunn, T., Heimberger, T., Schraud, H., Kressmann, S., Einsele, H., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.066175 · Cited by 162 · see citing works

FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells

Ni, L., Yang, C.-S., Gioeli, D., Frierson, H., Toft, D. O., & Paschal, B. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01891-08 · Cited by 155 · see citing works

Molecular mechanism of thermosensory function of human heat shock transcription factor Hsf1

Hentze, N., Breton, L. L., Wiesner, J., Kempf, G., & Mayer, M. P. (2016) · eLife · doi:10.7554/elife.11576 · Cited by 158 · see citing works

Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents

Li, X., Srinivasan, S. R., Connarn, J. N., Ahmad, A., Young, Z. T., Kabza, A. M., Zuiderweg, E. R. P., Sun, D., & Gestwicki, J. E. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400204n · Cited by 154 · see citing works

HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates

Bonam, S. R., Ruff, M., & Muller, S. (2019) · Cells · doi:10.3390/cells8080849 · Cited by 143 · see citing works

HSP70 Inhibition by the Small-Molecule 2-Phenylethynesulfonamide Impairs Protein Clearance Pathways in Tumor Cells

Leu, J. I.-J., Pimkina, J. S., Pandey, P., Murphy, M. E., & George, D. L. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0019 · Cited by 140 · see citing works

PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer

Yang, T., Ren, C., Qiao, P., Han, X., Wang, L., Lv, S., Sun, Y., Liu, Z., Du, Y., & Yu, Z. (2018) · Oncogene · doi:10.1038/s41388-018-0386-x · Cited by 137 · see citing works

Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors

Smith, J. R., Clarke, P. A., de Billy, E., & Workman, P. (2008) · Oncogene · doi:10.1038/onc.2008.380 · Cited by 134 · see citing works

Validation of the Hsp70–Bag3 Protein–Protein Interaction as a Potential Therapeutic Target in Cancer

Li, X., Colvin, T. A., Rauch, J. N., Acosta‐Alvear, D., Kampmann, M., Dunyak, B. M., Hann, B. C., Aftab, B. T., Murnane, M., Cho, M. Y., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0650 · Cited by 133 · see citing works

Sigma-1 Receptor Chaperones and Diseases

Tsai, S., Hayashi, T., Mori, T., & Su, T. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524910909030184 · Cited by 130 · see citing works

Pharmacological Targeting of the Hsp70 Chaperone

Patury, S., Miyata, Y., & Gestwicki, J. E. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789895674 · Cited by 128 · see citing works

Pyrrolo[2,3‐ d ]pyrimidine (7‐deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides

Perlíková, P., & Hocek, M. (2017) · Medicinal Research Reviews · doi:10.1002/med.21465 · Cited by 125 · see citing works

HSP90 empowers evolution of resistance to hormonal therapy in human breast cancer models

Whitesell, L. J., Santagata, S., Mendillo, M. L., Lin, N., Proia, D. A., & Lindquist, S. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421323111 · Cited by 119 · see citing works

Hsp70: Anti-apoptotic and Tumorigenic Protein

Rérole, A.-L., Jego, G., & Garrido, C. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-295-3_16 · Cited by 118 · see citing works

A Small Molecule Inhibitor of ATPase Activity of HSP70 Induces Apoptosis and Has Antitumor Activities

Ko, S., Kim, J., Na, D. C., Park, S., Park, S., Hyun, J. Y., Baek, K.-H., Kim, N. D., Kim, N.-K., Park, Y. N., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.02.004 · Cited by 118 · see citing works

Freezability prediction of boar ejaculates assessed by functional sperm parameters and sperm proteins

Casas, I., Sancho, S., Briz, M. D., Pinart, E., Bussalleu, E., Yeste, M., & Bonet, S. (2009) · Theriogenology · doi:10.1016/j.theriogenology.2009.07.001 · Cited by 118 · see citing works

Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer

Liu, C., Lou, W., Yang, J. C., Liu, L., Armstrong, C. M., Lombard, A. P., Zhao, R., Noel, O. D. V., Tepper, C. G., Chen, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07178-x · Cited by 117 · see citing works

Human DNAJ in cancer and stem cells

Sterrenberg, J. N., Blatch, G. L., & Edkins, A. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.019 · Cited by 116 · see citing works

Plasmodial heat shock proteins: targets for chemotherapy

Shonhai, A. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00639.x · Cited by 113 · see citing works

Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein–Protein Interactions with Heat Shock Protein 70 (Hsp70)

Shao, H., Li, X., Moses, M. A., Gilbert, L. A., Kalyanaraman, C., Young, Z. T., Chernova, M., Journey, S. N., Weissman, J. S., Hann, B. C., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00583 · Cited by 109 · see citing works

The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78

Roué, G., Pérez‐Galán, P., Mozos, A., López‐Guerra, M., Xargay‐Torrent, S., Rosich, L., Saborit-Villarroya, I., Normant, E., Campo, E., & Colomer, D. (2010) · Blood · doi:10.1182/blood-2010-04-278853 · Cited by 109 · see citing works

The Centrosome, a Multitalented Renaissance OrganellePreprint

Vertii, A., Hehnly, H., & Doxsey, S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a025049 · Cited by 108 · see citing works

Exploiting the Cancer Genome: Strategies for the Discovery and Clinical Development of Targeted Molecular Therapeutics

Yap, T. A., & Workman, P. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134532 · Cited by 104 · see citing works

A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent

Balaburski, G. M., Leu, J. I.-J., Beeharry, N., Hayik, S. A., Andrake, M., Zhang, G., Herlyn, M., Villanueva, J., Dunbrack, R. L., Yen, T. J., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0547-t · Cited by 106 · see citing works

HSP90 inhibition: two-pronged exploitation of cancer dependencies

Travers, J., Sharp, S. Y., & Workman, P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.021 · Cited by 105 · see citing works

A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress

Li, D., Yallowitz, A. R., Ozog, L. S., & Marchenko, N. D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.158 · Cited by 101 · see citing works

Crystal Structure of the Stress-Inducible Human Heat Shock Protein 70 Substrate-Binding Domain in Complex with Peptide Substrate

Zhang, P., Leu, J. I.-J., Murphy, M. E., George, D. L., & Marmorstein, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103518 · Cited by 99 · see citing works

Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells

Eskew, J. D., Sadikot, T., Morales, P., Duren, A., Dunwiddie, I., Swink, M., Zhang, X., Hembruff, S. L., Donnelly, A. C., Rajewski, R. A., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-468 · Cited by 96 · see citing works

Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib

Neznanov, N. S., Komarov, A. P., Neznanova, L., Stanhope-Baker, P., & Gudkov, A. V. (2011) · Oncotarget · doi:10.18632/oncotarget.246 · Cited by 90 · see citing works

Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer

Yang, T., Ren, C., Qiao, P., Han, X., Wang, L., Lv, S., Sun, Y., Liu, Z., Du, Y., & Yu, Z. (2019) · Oncogene · doi:10.1038/s41388-019-0982-4 · Cited by 90 · see citing works

Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond

Lang, B. J., Guerrero-Gimenez, M. E., Prince, T. L., Ackerman, A., Bonorino, C., & Calderwood, S. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184507 · Cited by 90 · see citing works

Structure and function of Hip, an attenuator of the Hsp70 chaperone cycle

Li, Z., Hartl, F. U., & Bracher, A. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2608 · Cited by 87 · see citing works

Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis

Le, M., Hunt, C. R., Yaglom, J. A., Gabai, V. L., & Sherman, M. Y. (2011) · Oncogene · doi:10.1038/onc.2011.5 · Cited by 87 · see citing works

Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition

Hackl, C., Lang, S. A., Moser, C., Mori, A., Fichtner‐Feigl, S., Hellerbrand, C., Dietmeier, W., Schlitt, H. J., Geissler, E. K., & Stoeltzing, O. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-668 · Cited by 86 · see citing works

Facilitating Akt Clearance via Manipulation of Hsp70 Activity and Levels

Koren, J., Jinwal, U. K., Jin, Y., O’Leary, J. C., Jones, J. R., Johnson, A. G., Blair, L. J., Abisambra, J. F., Chang, L., Miyata, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057208 · Cited by 85 · see citing works

The HSP90AA1 sperm content and the prediction of the boar ejaculate freezability

Casas, I., Sancho, S., Ballester, J., Briz, M. D., Pinart, E., Bussalleu, E., Yeste, M., Fàbrega, A., Rodríguez-Gil, J. E., & Bonet, S. (2010) · Theriogenology · doi:10.1016/j.theriogenology.2010.04.021 · Cited by 82 · see citing works

Maslinic acid induces autophagy by down‐regulating HSPA8 in pancreatic cancer cells

Tian, Y., Xu, H., Farooqı, A. A., Nie, B., Chen, X., Su, S., Yuan, R., Qiao, G., Li, C., Li, X., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6064 · Cited by 80 · see citing works

DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network

Hammond, C. M., Bao, H., Hendriks, I. A., Carraro, M., García-Nieto, A., Liu, Y., Reverón-Gómez, N., Spanos, C., Chen, L., Rappsilber, J., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.041 · Cited by 79 · see citing works

Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease

Kirk, J. A., Cheung, J. Y., & Feldman, A. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149415 · Cited by 76 · see citing works

Tanespimycin: the opportunities and challenges of targeting heat shock protein 90

Erlichman, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902953699 · Cited by 78 · see citing works

Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma

Davenport, E. L., Zeisig, A., Aronson, L. I., Moore, H. E., Hockley, S. L., Gonzalez, D., Smith, E. M. K., Powers, M. V., Sharp, S. Y., Workman, P., et al. (2010) · Leukemia · doi:10.1038/leu.2010.168 · Cited by 77 · see citing works

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia

Kaiser, M., Kühnl, A., Reins, J., Fischer, S., Ortiz-Tánchez, J., Schlee, C., Mochmann, L. H., Heesch, S., Benlasfer, O., Hofmann, W.-K., et al. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.28 · Cited by 76 · see citing works

Bag1 directly routes immature BCR-ABL for proteasomal degradation

Tsukahara, F., & Maru, Y. (2010) · Blood · doi:10.1182/blood-2009-10-249623 · Cited by 73 · see citing works

pH-Responsive NIR-Absorbing Fluorescent Polydopamine with Hyaluronic Acid for Dual Targeting and Synergistic Effects of Photothermal and Chemotherapy

Kim, S., In, I., & Park, S. Y. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00267 · Cited by 73 · see citing works

Aptamer-Dendrimer Functionalized Magnetic Nano-Octahedrons: Theranostic Drug/Gene Delivery Platform for Near-Infrared/Magnetic Resonance Imaging-Guided Magnetochemotherapy

Chen, Z., Peng, Y., Li, Y., Xie, X., Wei, X., Yang, G., Zhang, H., Li, N., Li, T., Qin, X., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c06667 · Cited by 73 · see citing works

Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells

Piaz, F. D., Cotugno, R., Lepore, L., Vassallo, A., Malafronte, N., Lauro, G., Bifulco, G., Belisario, M. A., & Tommasi, N. D. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.01.030 · Cited by 73 · see citing works

Inducible Hsp70 in the Regulation of Cancer Cell Survival: Analysis of Chaperone Induction, Expression and Activity

Zorzi, E., & Bonvini, P. (2011) · Cancers · doi:10.3390/cancers3043921 · Cited by 73 · see citing works

Heat shock proteins in multiple myeloma

Zhang, L., Fok, J. H. L., & Davies, F. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1584 · Cited by 71 · see citing works

ATPases as Drug Targets: Insights from Heat Shock Proteins 70 and 90

Massey, A. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100342z · Cited by 68 · see citing works

Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90

Wang, H., Tsai, Y.-L., Wu, Y., Chang, F., Liu, M.-H., Chen, W.-Y., & Wu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037764 · Cited by 66 · see citing works

HSP90 expression correlation with the freezing resistance of bull sperm

Wang, P., Wang, Y., Wang, H., Wang, C., Zan, L., Hu, J., Li, Q., Jia, Y., & Ma, G.-J. (2013) · Zygote · doi:10.1017/s096719941300004x · Cited by 65 · see citing works

The Novolactone Natural Product Disrupts the Allosteric Regulation of Hsp70

Hassan, A., Kirby, C. A., Zhou, W., Schuhmann, T., Kityk, R., Kipp, D. R., Baird, J., Chen, J., Chen, Y., Chung, F. S., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.11.007 · Cited by 62 · see citing works

The Double-Edged Sword: Conserved Functions of Extracellular Hsp90 in Wound Healing and Cancer

Hance, M. W., Nolan, K. D., & Isaacs, J. S. (2014) · Cancers · doi:10.3390/cancers6021065 · Cited by 62 · see citing works

Molecular Cochaperones: Tumor Growth and Cancer Treatment

Calderwood, S. K. (2013) · Scientifica · doi:10.1155/2013/217513 · Cited by 63 · see citing works

Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls

Bohonowych, J. E. S., Gopal, U., & Isaacs, J. S. (2010) · Journal of Oncology · doi:10.1155/2010/412985 · Cited by 63 · see citing works

Targeting heat shock factor 1 with a triazole nucleoside analog to elicit potent anticancer activity on drug-resistant pancreatic cancer

Xia, Y., Liu, Y., Rocchi, P., Wang, M., Fan, Y., Qu, F., Iovanna, J., & Peng, L. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.09.043 · Cited by 63 · see citing works

Heat Shock Protein 90 Ensures Efficient Mumps Virus Replication by Assisting with Viral Polymerase Complex Formation

Katoh, H., Kubota, T., Nakatsu, Y., Tahara, M., Kidokoro, M., & Takeda, M. (2017) · Journal of Virology · doi:10.1128/jvi.02220-16 · Cited by 63 · see citing works

Molecular chaperones in mammary cancer growth and breast tumor therapy

Calderwood, S. K., & Gong, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23461 · Cited by 62 · see citing works

Heat Shock Protein as Molecular Targets for Breast Cancer Therapeutics

Kim, L. S., & Kim, J. H. (2011) · Journal of Breast Cancer · doi:10.4048/jbc.2011.14.3.167 · Cited by 62 · see citing works

Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations

Yaglom, J. A., Wang, Y., Li, A., Li, Z., Monti, S., Alexandrov, I. M., Lu, X., & Sherman, M. Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-14900-0 · Cited by 62 · see citing works

Heat shock proteins as biomarkers of lung cancer

Mittal, S., & Rajala, M. S. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1736482 · Cited by 62 · see citing works

Targeting Allosteric Control Mechanisms in Heat Shock Protein 70 (Hsp70)

Li, X., Shao, H., Taylor, I. R., & Gestwicki, J. E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413140911 · Cited by 61 · see citing works

Reducible Branched Ester-Amine Quadpolymers (rBEAQs) Codelivering Plasmid DNA and RNA Oligonucleotides Enable CRISPR/Cas9 Genome Editing

Rui, Y., Wilson, D. R., Sanders, K., & Green, J. J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20206 · Cited by 61 · see citing works

Contributions of Co-Chaperones and Post-Translational Modifications Towards Hsp90 Drug Sensitivity

Walton‐Diaz, A., Khan, S., Bourboulia, D., Trepel, J. B., Neckers, L., & Mollapour, M. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.88 · Cited by 59 · see citing works

Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia

Pelz, J. O. W., Vetterlein, M. W., Grimmig, T., Kerscher, A., Moll, E.-M., Lazariotou, M., Matthes, N., Faber, M., Germer, C., Waaga-Gasser, A. M., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2784-6 · Cited by 61 · see citing works

The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer

Hoter, A., Rizk, S. E., & Naim, H. Y. (2019) · Cancers · doi:10.3390/cancers11081194 · Cited by 63 · see citing works

Targeting HSF1 sensitizes cancer cells to HSP90 inhibition

Chen, Y., Chen, J., Loo, A. T., Jaeger, S. A., Bagdasarian, L., Yu, J., Chung, F. S., Korn, J. M., Ruddy, D. A., Guo, R., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.991 · Cited by 60 · see citing works

Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications

Neznanov, N. S., Gorbachev, A. V., Neznanova, L., Komarov, A. P., Gurova, K. V., Gasparian, A. V., Banerjee, A. K., Almasan, A., Fairchild, R. L., & Gudkov, A. V. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10179 · Cited by 59 · see citing works

Heat Shock Protein 70 Inhibitors. 1. 2,5′-Thiodipyrimidine and 5-(Phenylthio)pyrimidine Acrylamides as Irreversible Binders to an Allosteric Site on Heat Shock Protein 70

Kang, Y., Taldone, T., Patel, H. J., Patel, P. D., Rodina, A., Gozman, A., Maharaj, R., Clement, C. C., Patel, M. R., Brodsky, J. L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401551n · Cited by 59 · see citing works

Functional characterization and proteomic analysis of the nucleocapsid protein of porcine deltacoronavirus

Lee, S.-H., & Lee, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.06.013 · Cited by 59 · see citing works

Heat Shock Proteins In Cancer: Targeting the ‘Chaperones’

Nahleh, Z. A., Tfayli, A., Najm, A. A. A. M., Sayed, A. E., & Nahle, Z. A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.50 · Cited by 57 · see citing works

Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets

Rai, R., Kennedy, A. L., Isingizwe, Z. R., Javadian, P., & Benbrook, D. M. (2021) · Cells · doi:10.3390/cells10112996 · Cited by 56 · see citing works

Pifithrin-μ, an Inhibitor of Heat-Shock Protein 70, Can Increase the Antitumor Effects of Hyperthermia Against Human Prostate Cancer Cells

Sekihara, K., Harashima, N., Tongu, M., Tamaki, Y., Uchida, N., Inomata, T., & Harada, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078772 · Cited by 56 · see citing works

Heat shock cognate protein 70 isoform D is required for clathrin-dependent endocytosis of Japanese encephalitis virus in C6/36 cells.

Chuang, C.-K., Yang, T.-H., Chen, T.-H., Yang, C.-F., & Chen, W.-J. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000015 · Cited by 57 · see citing works

Sensitizing tumor cells to radiation by targeting the heat shock response

Schilling, D., Kühnel, A., Konrad, S., Tetzlaff, F., Bayer, C., Yaglom, J. A., & Multhoff, G. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.033 · Cited by 55 · see citing works

Death by chaperone: HSP90, HSP70 or both?

Powers, M. V., Clarke, P. A., & Workman, P. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7583 · Cited by 99 · see citing works

Abstract 4772: Addiction to chaperones: Investigating the role of HSP70 isoforms in cancer

Suckling, L. A., Powers, M. V., Sharp, S. Y., & Workman, P. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-4772

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

Massey, A. J., Williamson, D. S., Browne, H. L., Murray, J. B., Dokurno, P., Shaw, T., Macias, A. T., Daniels, Z., Geoffroy, S., Dopson, M., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1194-3 · Cited by 314 · see citing works

Targeting the two major isoforms of heat shock protein 70: A novel approach to inhibiting the molecular chaperone heat shock protein 90

Powers, M. V., Clarke, P. A., & Wokman, P. (2006) · Cancer Research

Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanismsPreprint

Rohde, M., Daugaard, M., Jensen, M. H., Helin, K., Nylandsted, J., & Jäättelä, M. (2005) · Genes & Development · doi:10.1101/gad.305405 · Cited by 417 · see citing works